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Edited by Judit Ova´diAbstract In protein deposition disorders, a normally soluble
protein is deposited as insoluble aggregates, referred to as amy-
loid. The intrinsic eﬀects of speciﬁc mutations on the rates of
protein aggregation and amyloid formation of unfolded polypep-
tide chains can be correlated with changes in hydrophobicity,
propensity to convert a-helical to b sheet conformation and
charge. In this paper, we report the aggregation rates of buﬀalo,
horse and bovine apomyoglobins. The experimental values were
compared with the theoretical ones evaluated considering the
amino acid diﬀerences among the sequences. Our results show
that the mutations which play critical roles in the rate-determin-
ing step of apomyoglobin aggregation are those located within
the N-terminal region of the molecule.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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A large family of human diseases is characterized by the
presence, in tissues, of highly ordered insoluble protein aggre-
gates known as amyloid ﬁbrils [1]. The aggregation process is
generally believed to initiate from partially folded or com-
pletely unfolded states of proteins normally present in tissues
in soluble form [2]. The events leading to the transformation
of a soluble protein into insoluble amyloid ﬁbrils consist of a
conformational change which exposes part of the main-chain
and hydrophobic residues to the solvent under conditions in
which intermolecular interactions can take place. This process
leads to the formation of species competent for self-association
which assemble into amyloid ﬁbrils following a nucleation–
polymerization mechanism [3].
Microscopic and X-ray techniques indicate that the mor-
phology of ﬁbrillar aggregates shares common features even
if the proteins involved diﬀer in their sequence and native
structure. Fibrils are straight and unbranched, 5–10 nm wide,Abbreviations: ThT, Thioﬂavin T; Mb, myoglobin
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doi:10.1016/j.febslet.2006.02.018and characterized by b-strands oriented perpendicularly to
the long axis of the ﬁbril [4–8].
Moreover, proteins which are not involved in any disease are
also able to form amyloid ﬁbrils which are morphologically
and structurally indistinguishable from those formed by path-
ological proteins [9–14]. Therefore, the ability to form amyloid
could be a generic property of proteins closely linked to main-
chain interactions [15–17]. However, the extent and rate of
ﬁbril formation are related to side-chain properties [18,19].
The propensity of a given protein to aggregate and form
amyloid ﬁbrils under speciﬁc conditions depends dramatically
on its amino acid sequence. Some human genetic amyloid dis-
eases are caused by point mutations [20–22]. The mechanism
by which a mutation increases the aggregation propensity
has not yet been understood perfectly. It is believed that some
mutations destabilize the native state favoring the formation of
partially folded states which are more prone to aggregation.
This is because hydrophobic residues, which are largely buried
within the core of the native protein, become more exposed [3].
Nevertheless, in some amyloidoses, the aggregation involves
direct self-assembly of unstructured protein conformations
[23].
It has been shown that intrinsic eﬀects of speciﬁc mutations
on the rate of aggregation of unfolded polypeptide chains can
be related to changes of physicochemical properties such as
hydrophobicity (DHy), propensity to convert from a-helical
to b-sheet (DDGa-coil + DDGcoil-b) and overall charge (DQ)
[24]. The variation in aggregation rate caused by a mutation
is related to the contributions of these three independent and
additive factors by the relationship:
ln
mmut
mwt
 
¼ ADHyþ BðDDGa-coil þ DDGcoil-bÞ þ CDQ; ð1Þ
where A = 0.633, B = 0.198 and C = 0.491 [24]. The negative
C value results from the fact that the eﬀect of net charge on
protein aggregation and amyloidogenicity is in opposition to
the other two factors [25].
The aim of this study is to relate the variations in the amy-
loid aggregation rates of mammal apomyoglobins to the diﬀer-
ences in amino acid sequence. Even apomyoglobin, a globular
protein which contains only a-helical structures, forms amyloid
ﬁbrils due to association of unfolded polypeptide segments if
incubated at 65 C and at pH 9.0 [12,26]. The aggregation rates
of buﬀalo, horse and bovine apomyoglobins were measured.
These proteins can be considered natural mutants becauseblished by Elsevier B.V. All rights reserved.
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ences observed were compared to the theoretical ones calcu-
lated by using Eq. (1). The results demonstrate that the
variations in amyloid aggregation kinetics are related only to
the amino acid diﬀerences in the N-terminal region of the pro-
teins. This suggests that the N-terminal region is involved in
the rate-determining step of apomyoglobin aggregation.2. Materials and methods
2.1. Apomyoglobins
Buﬀalo and bovine myoglobins (Mbs) were puriﬁed from longissimus
dorsi essentially using the procedure reported by Balestrieri et al. [27]
with some modiﬁcations.
Frozen muscle was thawed overnight at 4 C, partially freed of gross
fat and connective tissue, cut into small pieces, that were placed in
Milli Q water (1:1; w:v) and homogenated in a Waring Blender homog-
enizer. The homogenate was then centrifuged at 14000 rpm for 40 min
at 4 C, and the supernatant was ﬁltered through Mirachlot paper
(Calbiochem, San Diego – USA) to remove fatty material. The clear
ﬁltrate was then dialyzed, using a Spectra/Por membrane (molecular
mass cut oﬀ 6000–8000) against Milli Q water. The white precipitate
formed during the dialysis was removed by centrifugation at
14000 rpm for 15 min. 20 mL of the supernatant (protein concentra-
tion about 10 mg/mL) were gel-ﬁltered onto a S-Sephacryl column
(/ 2.6 · 115 cm, Amersham Pharmacia Biotech, Milano – Italy), equil-
ibrated with 25 mM NaH2PO4–0.35 M NaCl buﬀer, pH 7.2. The col-
umn was then eluted with the same buﬀer at a ﬂow rate of 35 mL/h,
collecting 5 mL fractions. The eluate was monitored at 280 and
409 nm.
The Mb-containing fractions were concentrated on an ultraﬁltration
cell (Amicon Inc., Beverly, USA), using a membrane with molecular
mass cut-oﬀ 10000, and then dialyzed against 10 mM Tris Æ Cl, pH
8.6 (Buﬀer A). The dialyzed protein solution was centrifuged at
14000 rpm for 15 min, at 4 C. The supernatant was absorbed onto
a DEAE–Sepharose column (/ 3 · 8 cm, BioRad, Milano, Italy),
equilibrated with Buﬀer A and eluted with a gradient made up by Buf-
fer A and Buﬀer B (10 mM Tris Æ Cl, pH 8.6 containing 0.5 M NaCl),
at a ﬂow rate of 1.5 mL/min. The eluate absorbance was measured at
280 and 409 nm and the sample purity checked by SDS–PAGE.
Horse Mb from skeletal muscle was obtained from Sigma.
The heme was removed fromMbs by the 2-butanone extraction pro-
cedure [28]. Protein concentrations were determined measuring
absorption (Jasco V-550 spectrophotometer) at 280 nm using
13500 M1 cm1 as molar extinction coeﬃcient [29].Fig. 1. Time dependence of ThT ﬂuorescence (ﬁlled black symbols)
and far UV CD at 216 nm (open black symbols) of buﬀalo (square),
bovine (circles) and horse (triangles) apomyoglobins. The continuous
lines through the data are the best ﬁts to single exponential functions.
The kinetics measured from both techniques are in close agreement.2.2. Aggregation kinetics
Apomyoglobin ﬁbrils were obtained incubating 40 lM of protein in
50 mM sodium borate, pH 9.0 at 65 C [12]. Aggregation was moni-
tored by Thioﬂavin T (ThT) ﬂuorescence and far UV CD at 216 nm.
Fibril formation was conﬁrmed by AFM images.
Aliquots of proteins were taken at diﬀerent times and mixed with
25 lM of ThT. The molar ratio protein/ThT was 2:5. ThT ﬂuorescence
was determined by a Perkin–Elmer Life Sciences LS 55 spectroﬂuorim-
eter at the excitation and emission wavelengths of 450 and 482 nm,
respectively. The ﬂuorescence intensity at 482 nm was corrected by
subtracting the emission intensity recorded before the addition of pro-
tein to thioﬂavin T solutions.
Far UV CDmeasurements were performed on a Jasco J-715 spectro-
polarimeter using thermostated quartz cells of 0.1 cm path length.
Fluorescence intensity was plotted as function of time and interpo-
lated to single exponential function as
y ¼ y0 þ Ke
t
s; ð2Þ
where s is the inverse of aggregation rate (m), y0 is the maximal signal
intensity corresponding to the maximal aggregation and K the diﬀer-
ence between the maximal and the initial signal intensity. Diﬀerences
in the protein aggregation rate were expressed as ln(m/mref)exp, where
m is the aggregation rate of the given protein and mref is that of the ref-
erence protein [19].3. Results and discussion
In this paper, we compare the aggregation rates of buﬀalo
and horse apomyoglobins with that of bovine apomyoglobin
which we used as a reference protein. Aggregation rates were
determined following the time dependence of ThT ﬂuorescence
and CD ellipticity at 216 nm upon incubation of proteins at
pH 9.0 and 65 C. In these conditions, apomyoglobin is desta-
bilized and forms ﬁbrillar aggregates as indicated by electron
microscopy [12,26]. ThT is a ﬂuorescent dye which is known
to detect reliably the formation of amyloid ﬁbrils due to the
signiﬁcant increase in its emission intensity upon binding to
the linear array of b-strands [30]. The aggregation kinetics
was also probed by Congo Red absorption (data not shown).
The kinetic traces were highly reproducible, and the rates
determined using the three techniques were closely correlated.
Fig. 1 shows the aggregation kinetics of the three examined
proteins monitored by ThT ﬂuorescence intensity at 482 nm
and far UV CD at 216 nm. The aggregation kinetics show an
exponential growth phase, characteristic of nucleation-depen-
dent polymerization [15]. A lag phase was not evident proba-
bly because of the temperature-induced increase of
aggregation rate. The data were ﬁtted to single exponential
functions (Eq. (2)). The ﬁt parameters and the corresponding
reduced chi-square, v2, are reported in Table 1. The aggrega-
tion rates (m) of buﬀalo and horse apomyoglobins were found
signiﬁcantly greater than that of bovine apomyoglobin.
The diﬀerences in aggregation kinetics were evaluated as
ln (m/mref)exp using bovine apomyoglobin as a reference. The
amino acid sequences of the three examined proteins are
shown in Fig. 2. For each substitution, we calculated the
changes of charge (DQ), hydrophobicity (DHy) and beta pro-
pensity (DDGa-coil + DDGcoil-b) (Table 2) using the values re-
ported in the literature [24]. Using Eq. (1), we obtained the
theoretical value ln (m/mref)i for the ith mutation (starting from
N-terminus):
ln
m
mref
 
i
¼ ADHyi þ BðDDGa-coil þ DDGcoil-bÞi þ CDQi.
Table 1
Best ﬁt parameters of the aggregation kinetics for buﬀalo, bovine and
horse apomyoglobins
Buﬀalo Bovine Horse
K 180 ± 5 158 ± 4 154 ± 6
y0 213 ± 3 210 ± 2 209 ± 2
s (h) 2.9 ± 0.6 7 ± 2 2.8 ± 0,7
m (h1) 0.34 ± 0.07 0.14 ± 0.04 0.36 ± 0.09
v2 1.1 0.9 1.1
Table 2
Physicochemical changes relative to amino acid diﬀerences of buﬀalo
and horse Mbs with respect to bovine Mb used as a referencea
Mutation Helix DHy DDGa-coil + DDGcoil-b DQ ln (m/mref)
Bovine Mbﬁ buﬀalo Mb
A19T B 1.39 8.42 0 0.80
A117D G 4.2 3.38 1 3.82
D141E H 0.9 2.78 0 1.12
Bovine Mbﬁ horse Mb
L9Q A 3.12 3.63 0 1.26
A13V A 0.91 7.01 0 1.96
V21I B 0.52 0.56 0 0.22
N66T E 0.91 4.67 0 1.50
T67V E 2.3 0.95 0 1.27
V86L F 0.52 2.67 0 0.20
H88P F 1.63 5.11 0 2.04
E91Q F 1.61 0.14 1 1.54
N95T / 0.91 4.67 0 1.50
V101I G 0.52 0.56 0 0.22
A117S G 1.63 2.32 0 0.57
S121G H 1.24 4.09 0 0.03
A129G H 0.39 1.50 0 0.05
S132T H 0.24 3.12 0 0.77
M142I H 0.86 2.30 0 1.00
Q145K H 1.47 0.08 1 1.44
V148E H 4.21 3.00 1 3.75
H152Q / 0.66 0.41 0 0.34
aThese changes were evaluated using the data reported in reference
[24].
Table 3
Experimental and theoretical variations of the aggregation rates of
buﬀalo and horse apomyoglobins with respect to bovine apomyoglo-
bin used as a reference
ln(m/mref)exp ln (m/mref)theor ln (m/mref)N-term
Bovineﬁ buﬀalo 0.88 ± 0.09 1.90 0.80
Bovineﬁ horse 0.91 ± 0.04 4.48 0.92
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and horse apomyoglobins with respect to bovine apomyoglo-
bin were evaluated by the sum of terms ln(m/mref)i correspond-
ing to each mutation:
ln
mbuf
mbov
 
theor
¼
X3
i¼1
ln
mbuf
mbov
 
i
;
ln
mhorse
mbov
 
theor
¼
X18
i¼1
ln
mhorse
mbov
 
i
.
In Table 3, the theoretical diﬀerences in the aggregation rate
are reported. It is clear that they signiﬁcantly diﬀer from the
experimentally measured values. The discrepancy between
experimental and theoretical values suggests that aggregation
may not involve the overall polypeptide chain but only some
polypeptide segments, in particular those which are more
prone to aggregate. It is not known which apomyoglobin seg-
ments are involved in the formation of amyloid ﬁbrils. How-
ever, peptide fragments corresponding to the N-terminal
region or to the G-helix of Mb have been previously shown
to form species with extensive b-structure [31,32]. In this re-
spect, our attention was turned to identify the protein regions
which determine the observed aggregation rate variations. We
found that crucial substitutions are those present in the N-ter-
minal region of the protein. In this region, buﬀalo apomyoglo-
bin presents only one substitution, A19T, whereas horse
apomyoglobin shows three mutations: L9Q, A13V and V21I.
Although these substitutions are all relatively conservative,
they introduce changes in hydrophobicity and b sheet forma-
tion propensity (see Table 2) which increase the aggregation
rate. Moreover, many of them are natural mutations associ-
ated with familial diseases [24]. The close similarity of horse
and buﬀalo kinetics data (Fig. 1) is well correlated to the ami-Fig. 2. Comparison of amino acid sequences of buﬀalo, horse and bovine Mb
of buﬀalo Mb was determined by Dosi (unpublished results, see also [33]).no acid substitutions in the N-terminal region. In fact, the the-
oretical values, ln (m/mref)N-term, calculated from the contri-
butions supplied by these mutations (Table 3) were consistent
with the experimental values, the discrepancy being lower than
the experimental errors. On the contrary, the calculations rel-
ative to the other helical segments did not provide consistent
values. In particular, the mutations in the G helix lead tos. The amino acid diﬀerences are highlighted. The amino acid sequence
1684 S. Vilasi et al. / FEBS Letters 580 (2006) 1681–1684aggregation rates signiﬁcantly diﬀerent from the experimental
values.
In conclusion, the data reported here suggest that the N-ter-
minal region might form part of the sequence segment that is
relevant for the a to b transition of apomyoglobin from a glob-
ular state to amyloid ﬁbrils. The observation that the N-termi-
nal region of apomyoglobin is more hydrophobic than the rest
of the molecule and, thus, more prone to aggregate [31] further
corroborates our conclusion. Moreover, it has been reported
that mutations occurring in the A-helix, i.e., W7FW14F, result
in the expression of an amyloidogenic apomyoglobin with a
high propensity to form amyloid ﬁbrils under physiological
conditions [13,14].
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